MENIS, JESSICA
MENIS, JESSICA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)
2021 Dal Maso, A.; Pavan, A.; Ferro, A.; Pretelli, G.; Frega, S.; Menis, J.; Pasello, G.; Guarneri, V.; Conte, P. F.; Bonanno, L.
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)
2021 Lorenzi, M.; Dal Maso, A.; Ferro, A.; Polo, V.; Scattolin, D.; Macerelli, M.; Follador, A.; Targato, G.; Indraccolo, S.; Frega, S.; Menis, J.; Bonanno, L.; Guarneri, V.; Conte, P. F.; Pasello, G.
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center
2021 Pasello, G.; Menis, J.; Pilotto, S.; Frega, S.; Belluomini, L.; Pezzuto, F.; Calio, A.; Sepulcri, M.; Cernusco, N. L. V.; Schiavon, M.; Infante, M. V.; Damin, M.; Micheletto, C.; Del Bianco, P.; Giovannetti, R.; Bonanno, L.; Fantoni, U.; Guarneri, V.; Calabrese, F.; Rea, F.; Milella, M.; Conte, P.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
2021 Dal Maso, A; Lorenzi, M; Ferro, A; Pilotto, S; Cecere, F; Follador, A; Polo, V; Del Conte, A; Sartori, G; Giavarra, M; Scattolin, D; Indraccolo, S; Frega, S; De Maglio, G; Menis, J; Bonanno, L; Calabrese, F; Guarneri, V; Conte, P; Pasello, G
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?
2020 Menis, J.; Reck, M.
Combination of Immunotherapy and Radiotherapy—The Next Magic Step in the Management of Lung Cancer?
2020 Hendriks, L. E. L.; Menis, J.; De Ruysscher, D. K. M.; Reck, M.
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
2020 Boscolo, A.; Fortarezza, F.; Lunardi, F.; Comacchio, G.; Urso, L.; Frega, S.; Menis, J.; Bonanno, L.; Guarneri, V.; Rea, F.; Conte, P.; Calabrese, F.; Pasello, G.
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2020 Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer
2020 Pasello, G.; Pavan, A.; Attili, I.; Bortolami, A.; Bonanno, L.; Menis, J.; Conte, P.; Guarneri, V.
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2020 Passiglia, F.; Pilotto, S.; Facchinetti, F.; Bertolaccini, L.; Del Re, M.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
2019 Evangelista, L.; Cuppari, L.; Menis, J.; Bonanno, L.; Reccia, P.; Frega, S.; Pasello, G.
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer
2019 Tryfonidis, K.; Papadaki, C.; Assele, S.; Lagoudaki, E.; Menis, J.; Koutsopoulos, A.; Trypaki, M.; Tsakalaki, E.; Sfakianaki, M.; Hasan, B.; Stathopoulos, E.; Georgoulias, V.; Souglakos, J.
Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer
2019 Santarpia, Mariacarmela; Menis, Jessica; Chaib, Imane; Gonzalez Cao, Maria; Rosell, Rafael
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)
2019 Pasello, Giulia; Vicario, Giovanni; Zustovich, Fable; Oniga, Francesco; Gori, Stefania; Rosetti, Francesco; Bonetti, Andrea; Favaretto, Adolfo; Toso, Silvia; Redelotti, Roberta; Santo, Antonio; Bernardi, Daniele; Giovanis, Petros; Oliani, Cristina; Calvetti, Lorenzo; Gatti, Carlo; Palazzolo, Giovanni; Baretta, Zora; Bortolami, Alberto; Bonanno, Laura; Basso, Marco; Menis, Jessica; Corte, Donatella Da; Frega, Stefano; Guarneri, Valentina; Conte, Pierfranco
Prospects of targeted and immune therapies in SCLC
2019 Hendriks, L. E. L.; Menis, J.; Reck, M.
Responding to the challenges of international collaborations between the east and the west – Report of the first JCOG–EORTC symposium and a perspective from young JCOG and EORTC investigators
2019 Kataoka, K.; Kaider-Person, O.; Kasper, B.; Starlinger, P.; Caballero, C.; Menis, J.; Hendriks, L. E.; Terada, M.; Collette, L.; Nakamura, K.; Lacombe, D.; Fukuda, H.
Treatment duration of checkpoint inhibitors for NSCLC
2019 Remon, Jordi; Menis, Jessica; Aspeslagh, Sandrine; Besse, Benjamin
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
2018 Machiels, Jean-Pascal; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F.
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection
2018 Banna, Giuseppe Luigi; Passiglia, Francesco; Colonese, Francesca; Canova, Stefania; Menis, Jessica; Addeo, Alfredo; Russo, Antonio; Cortinovis, Diego Luigi
INTEGRATED CARE PATHWAYS in LUNG CANCER: A QUALITY IMPROVEMENT PROJECT
2018 Fasola, G.; Menis, J.; Follador, A.; De Carlo, E.; Valent, F.; Aresu, G.; De Pellegrin, A.; Giacomuzzi, F.; Iuri, D.; Lugatti, E.; Parisi, G.; Pacileo, G.